(Q40896876)

24 September 2017

Type 1 insulin-like growth factor receptor monoclonal antibody (HX-1162) treatment for liver cancer (English)

1 reference

24 September 2017

Xue-Hui Chen

1

1 reference

24 September 2017

Zhi-Qiang Li

2

1 reference

24 September 2017

Hua Peng

3

1 reference

24 September 2017

Su-Mei Jin

4

1 reference

24 September 2017

Hui-Qing Fu

5

1 reference

24 September 2017

Tie-Chui Zhu

6

1 reference

24 September 2017

Xiao-Gang Weng

7

1 reference

24 September 2017

language of work or name

English

0 references

publication date

14 May 2013

1 reference

24 September 2017

OncoTargets and Therapy

1 reference

24 September 2017

6

1 reference

24 September 2017

527-530

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

24 September 2017

start time

1 May 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660154

Management of recurrent hepatocellular carcinoma in liver transplant recipients: a systematic review.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660154

Pathways and targets in hepatocellular carcinoma

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660154

An overview of biomarkers for the diagnosis of hepatocellular carcinoma

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660154

Cellular and molecular mechanisms of hepatocellular carcinoma: an update

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660154

Molecular targeted therapies in hepatocellular carcinoma

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660154

Blockade of insulin-like growth factor type-1 receptor with cixutumumab (IMC-A12): a novel approach to treatment for multiple cancers

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660154

IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660154

IMC-A12, a human IgG1 monoclonal antibody to the insulin-like growth factor I receptor

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660154

Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660154

Surveillance for hepatocellular carcinoma

19 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23700371

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2147/OTT.S44162

1 reference

24 September 2017

1 reference

24 September 2017

PubMed publication ID

23700371

1 reference